Epicutantest-TROLAB[R] D0109 Imidazolidinylharnstoff 2% Salbe
Country: Ġermanja
Lingwa: Ġermaniż
Sors: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
1,1'-Methylenbis[3-(3-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)harnstoff]
Disponibbli minn:
SmartPractice Europe GmbH
INN (Isem Internazzjonali):
1,1'-methylene-bis [3- (3-hydroxymethyl-2,5-dioxoimidazolidin-4-yl) urea]
Għamla farmaċewtika:
Salbe
Kompożizzjoni:
1,1'-Methylenbis[3-(3-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)harnstoff] 2% (m/V)
L-istatus ta 'awtorizzazzjoni:
ungültig [HIST]
![1,1'-Methylenbis[3-(3-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)harnstoff]](/web/img/edge.svg){kind=small}